5.0 based on 11reviewsView this provider's reviews
Patient satisfaction ratings and reviews are based on personal opinions. Before you choose any doctor you should take into account their background, training, specialized experience AND their patient satisfaction to ensure they are the right fit for you.
Accepting new patients
Jia Ruan, M.D., Ph.D., is an Associate Professor of Clinical Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine. Dr. Ruan graduated summa cum laude from Washington University in St. Louis. She received comprehensive training in medicine and immunology leading to combined MD-PhD degrees from the Tri-Institutional Medical Scientist TrainingProgram of Cornell University, the Rockefeller University and Sloan-Kettering Cancer Institute. She completed internship and residency in internal medicine and started a clinical fellowship in Hematology at the Stanford University Medical Center. Returning to Cornell, Dr. Ruan completed a fellowship in Hematology and Medical Oncology at the New York Presbyterian Hospital. She is a member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Ruan's clinical practice includes patients with lymphoma, myeloma, and other hematological disorders. Following her long-standing interest in tumor immunology and vascular medicine, Dr. Ruan is actively involved in clinical and translational research aimed at development of novel therapeutics targeting tumor microenvironment. Her research efforts have been recognized and supported by competitive fundings from Cornell CARCC, the Lymphoma Research Foundation, the ASCO Foundation Young Investigator Award and the ASCO Foundation Junior Faculty Career Development Award, in addition to the K08 Clinical Scientist Career Development Award from the National Institute of Health (NHLBI).
Our lymphoma group practice provides specialized and multidisciplinary care in the setting of a leading medical institution for patients with all types of lymphomas. We strive to deliver the best possible standard of care, and take pride in our comprehensive clinical research program that provides access to state-of-the-art novel agents and combination treatments that continue to transform care for lymphoma patients, often years before they become widely available elsewhere. With a research background in tumor immunology and vascular medicine, my clinical research has been focused on developing new immunotherapy-based treatments that target the tumor microenvironment for a variety of lymphoma subtypes, including rare diseases such as mantle cell lymphoma and T-cell lymphoma. Another focus of mine is to develop low-intensity biologic-based treatments that minimize side effects and maximize quality-of-life. I believe in personalized, compassionate, and informed care that is tailored to each individual patient's needs.